Bavarian Nordic A/S - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BVNRY Over the counter 2834 www.bavarian-nordic.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bavarian Nordic A/S

Bavarian Nordic secures four-year UK vaccine supply deal - Nov 3rd, 2026 3:37 am
Bavarian Nordic – Completion of Share Buy-Back Program - Nov 2nd, 2026 12:51 am
Bavarian Nordic Awarded Multi-Year Vaccine Contract by UK Government - Nov 1st, 2026 11:30 pm
Bavarian Nordic to Supply and Donate Vaccines for Global Mpox Emergency Stockpile - Oct 27th, 2026 9:52 am
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - Oct 26th, 2026 2:57 am
Bavarian Nordic (CPSE:BAVA) Stock Could Be Undervalued Despite Its 64% Run - Oct 9th, 2026 9:11 am
Bavarian Nordic (CPSE:BAVA) Could Be 16% Below Fair Value As 2026 Guidance Rises - Oct 9th, 2026 4:13 am
Bavarian Nordic rises after guidance upgrade on U.S. rabies vaccine demand - Oct 8th, 2026 1:25 am
Bavarian Nordic Upgrades Full-Year 2026 Financial Guidance After Strong Travel Health Performance - Oct 7th, 2026 11:43 pm
What Bavarian Nordic’s next CEO is up against - Sep 28th, 2026 6:50 am
Bavarian Nordic – Notification of Holding of Treasury Shares - Sep 22nd, 2026 2:00 am
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic - Sep 16th, 2026 11:55 pm